Topically Applied Connective Tissue Growth Factor/CCN2 Improves Diabetic Preclinical Cutaneous Wound Healing: Potential Role for CTGF in Human Diabetic Foot Ulcer Healing

Figure 4

Wound collagen IV staining images. Representative images reflect that collagen IV is increased at day 14 in CTGF treated diabetic rodent wounds relative to the other groups and remained at a level similar to that observed at day 7.